As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 24, 2014
by Women’s Brain Health Initiative:
Men’s and women’s brains are different. They differ in size. They differ in amounts of white and grey matter. And they appear to differ in how they age, with differences becoming most pronounced in older age. These differences can be seen using brain imaging technology.
“New computerized methods allow precise measurement of the brain’s structure, opening up new understanding of how the brain changes with age and how dementia affects women and men differently,” explains Sandra Black, a neurology researcher affiliated with Sunnybrook Health Sciences Centre and University of Toronto.
What’s Different Between Women’s & Men’s Brains?
Black shares some of what we know about differences between men’s and women’s brains, thanks to brain imaging:
That last point about variations in head size is an important one. For analysis of brain imaging to be accurate when comparing across sexes, it is essential to make corrections for head size. To date, a lot of brain imaging work hasn’t done that as carefully as it should.
Brains Shrink Rapidly with Alzheimer’s
A healthy brain fills the space inside the skull. Over time, the brain shrinks, much more rapidly when Alzheimer’s disease is present. Brain imaging allows scientists to measure the amount of brain shrinkage by considering the volume of the brain itself as a percentage of the amount of space available inside the skull (the total intracranial vault volume); the resulting calculation is called the brain parenchymal fraction (BPF). BPF takes into account head size and makes it possible to compare across men and women. Women tend to have larger BPFs than men.
Further evidence of brain shrinkage is the enlarging of ventricles. Ventricles are spaces in the centre of the brain where ventricular cerebrospinal fluid is produced. As the brain shrinks, these enlarge – they are much bigger in Alzheimer’s patients. Black points out that, “older men tend to show more generalized shrinkage of the brain as indicated by larger ventricles, relative to head size.”
Current methods of brain imaging allow the brain to be segmented so that scientists can examine a particular part of the brain in isolation. The hippocampus is an interesting part to examine because of its importance for learning new information and forming short-term memories, and the fact that it is the first part of the brain to show signs of shrinking in Alzheimer’s patients. If you look at hippocampal volume in men and women, and don’t adjust for head size, it looks like men with Alzheimer’s disease have significantly larger hippocampal volume than women with Alzheimer’s. However, once you adjust for head size, this difference disappears. There is not much difference in hippocampus shrinkage between men and women with Alzheimer’s disease. So, in this area, we actually see a similarity between men and women.
Small Vessel Disease More Common in Women
Brain imaging can also reveal different types of small vessel disease that may affect cognition. There are different ways small vessel disease can show up. One is blockages in small arteries in the brain, especially common in people with hypertension and diabetes. “With this type of blockage, there is a kind of remodeling taking place in the brain and you get twisted arteries,” explains Black.
The tiny arteries can end up completely blocked because they don’t have any blood supply and you end up with a hole. That is called a silent stroke. Silent strokes are present in about 28 percent of the population over 65 and even though people are not aware they’ve had one, they are not benign. Silent strokes are associated with higher risk of experiencing dementia and having an overt stroke.
“The other way small vessel disease manifests in the body is through what we call White Matter Hyperintensities (WMH),” says Black. WMH shows up as tiny spots or patches that represent an area of circulatory failure that hasn’t developed into a hole. “You get this hyperintense appearance on a particular type of MRI scan,” explains Black. WMH are much more prevalent than silent strokes. US data from brain imaging of 3500 people over 65 years old showed that WMH was present in 95% of the sample.
“The presence of WMH tells us that the vessels are aging and parts of the brain are being hurt,” says Black. “Just because WMH are so common doesn’t mean they are benign. If you just have little bit of WMH, it probably doesn’t matter so much. But when you start to have large areas of them, it’s becoming a more diffuse disease, which is more of a concern. And it looks like there is a tendency for women to have this more than men.”
Small vessel disease in the brain is related to overall vascular health. To keep your brain healthy, you need to keep your heart and circulatory system healthy. So, that means eating well, exercising and managing things that impact heart health such as high blood pressure, obesity and diabetes. “So that means hypertension must be recognized even at age 20 or 30, and treated vigorously. We have good medicine now that can do that,” urges Black.
A lot is known about how the brain works and how women’s and men’s brains differ, thanks to brain imaging. More research is needed to help us understand why these differences exist and how recommended treatments might be different for each sex. This is a complex topic with much more learning still ahead.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.